Effect of sera on the adhesion of natural killer cells to the endothelium in severe pre-eclampsia

Journal of Obstetrics and Gynaecology Research

Volumn 32, Issue 5, 2006, Pages 443-448

  Wei, Jun ^a,b   Satomi, Misao ^a   Negishi, Yasuyuki ^a   Matsumura, Yoshikatsu ^a   Miura, Atsushi ^a   Nishi, Yayoi ^a   Asakura, Hirobumi ^a   Takeshita, Toshiyuki ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Adhesion; Endothelium; NK cell; Pre eclampsia

Indexed keywords

CELL ADHESION MOLECULE; CHROMIUM 51; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY; OCTOXINOL; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

ADULT; ARTICLE; CELL ADHESION; CELL COUNT; CELL INTERACTION; CELL ISOLATION; CELL LABELING; CELL LYSATE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MONOLAYER CULTURE; NATURAL KILLER CELL; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; SERUM; SOLUBILIZATION;

ADULT; CELL ADHESION; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; HUMANS; KILLER CELLS, NATURAL; PRE-ECLAMPSIA; PREGNANCY; SERUM; UMBILICAL VEINS;

EID: 33748762978     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2006.00444.x     Document Type: Article

References (37)

1. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McIaughlin MK. Pre-eclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200-1204.
2. Lyall F, Greer IA, Boswell F, Macara LM, Walker JJ, Kingdom JC. The cell adhesion molecule, VCAM-1, is selectively elevated in serum in pre-eclampsia: does this indicate the mechanism of leucocyte activation? Br J Obstet Gynecol 1994; 101: 485-487.
3. Aliefendioglu D, Erdem G, Tulek N, Yurdakok M. Neonatal and maternal serum levels of soluble ICAM-1 in pre-eclamptic and normal pregnancies. Am J Perinatol 2002; 19: 333-339.
4. Chaiworapongsa T, Romero R, Yoshimatsu J et al. Soluble adhesion molecule profile in normal pregnancy and preeclampsia. J Matern Fetal Neonatal Med 2002; 12: 19-27.
5. Heyl W, Handt S, Reister F, Gehlen J, Mittermayer C, Rath W. The role of soluble adhesion molecules in evaluating endothelial cell activation in pre-eclampsia. Am J Obstet Gynecol 1999; 180: 68-72.
6. Haller H, Ziegler EM, Homuth V, et al. Endothelial adhesion molecules and leukocyte integrins in pre-eclamptic patients. Hypertension 1997; 29: 291-296.
7. Nemmlander A, Saksela E, Hayrj P. Are natural killer cells involved in allograft rejection? Eur J Immunol 1983; 13: 348-350.
8. Allavena P, Paganin C, Martin-Padura I et al. Molecules and structures involved in the adhesion of natural killer cells to vascular endothelium. J Exp Med 1991; 173: 439-448.
9. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745-2756.
10. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of pre-eclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 2002; 9: 147-160.
11. Peer LA. Behavior of skin grafts exchanged between parents and offspring. Ann NY Acad Sci 1958; 73: 854-859.
12. Montgomery WP, Young RC, Aller MD, Horden KA. The tuberculin test in pregnancy. Am J Obstet Gynecol 1968; 100: 829-831.
13. Saito S, Umekage H, Sakamoto Y, Increased T. h1-type immunity and decreased Th2-type immunity in patients with pre-eclampsia. Am J Reprod Immunol 1999; 41: 297-306.
14. Sunder-Plassmann G, Derfler K, Wagner L et al. Increased serum activity of interleukin-2 in patients with pre-eclampsia. J Autoimmune 1989; 2: 203-205.
15. Daniel Y, Kupferminc MJ, Baram A et al. Plasma interleukin-12 is elevated in patients with pre-eclampsia. Am J Reprod Immunol 1998; 39: 376-380.
16. Allavena P, Paganin C, Zhou D, Bianchi G, Sozzani S, Mantovani A. Interleukin-12 is chemotactic for natural killer cells and stimulates their interaction with vascular endothelium. Blood 1994; 84: 2261-2268.
17. Paganin C, Matteucci C, Cenzuales S, Mantovani A, Allavena P. IL-4 inhibits binding and cytotoxicity of NK cells to vascular endothelium. Cytokine 1994; 6: 135-140.
18. Takaca P, Kauma SW, Sholley MM, Walsh SW, Dinsmoor MJ, Green K. Increased circulating lipid peroxides in severe pre-eclampsia activate NF-kB and upregulate ICAM-1 in vascular endothelial cells. FASEB 2001; 15: 279-282.
19. Van den Heuvel MJ, Horrocks J, Bashar S et al. Menstrual cycle hormones induce changes in functional interactions between lymphocytes and decidual vascular endothelial cells. J Clin Endocrinol Metab 2005; 90: 2835-2842.
20. Croy BA, Ashkar AA, Minhas K, Greenwood JD. Can murine uterine natural killer cells give insights into the pathogenesis of pre-eclampsia? J Soc Gynecol Invest 2000; 7: 12-20.
21. Gendron RL, Baines MG. Infiltrating decidual natural killer cells are associated with spontaneous abortion in mice. Cell Immunol 1988; 113: 261-267.
22. Takeshita T, Satomi M, Akira S, Nakagawa Y, Takahashi H, Araki T. Preventive effect of monoclonal antibodies to intercellular adhesion molecule-1 and leukocyte function-associate antigen-1 on murine spontaneous fetal resorption. Am J Reprod Immunol 2000; 43: 180-185.
23. Ntrivalas EI, Kwak-Kim JY, Gilman-Sachs A et al. Status of peripheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown aetiology. Hum Reprod 2001; 16: 855-861.
24. Matthiesen L, Berg G, Ernerudh J, Hakansson L. Lymphocyte subsets and mitogen stimulation of blood lymphocytes in pre-eclampsia. Am J Reprod Immunol 1999; 41: 192-203.
25. Darmochwal-Kolarz D, Rolinski J, Leszczynska-Goarzelak B, Oleszczuk J. The expressions of intracellular cytokines in the lymphocytes of pre-eclamptic patients. Am J Reprod Immunol 2002; 48: 381-386.
26. Damle NK, Doyle LV. IL-2 activated human killer lymphocytes but not their secreted products mediate increase in albumin flux across cultured endothelial monolayers. J Immunol 1989; 142: 2660-2669.
27. Kitayama J, Tsuno N, Yasuhara H et al. Lysis of endothelial cells by autologous lymphokine-activated killer cells. Cancer Immunol Immunother 1994; 38: 317-322.
28. Merhi-Soussi F, Dominguez Z, Macovschi O, Dubois M, Savany Alain Lagarde M, Prigent AF. Human lymphocytes stimulate prostacyclin synthesis in human umbilical vein endothelial cells. Involvement of endothelial c PLA2. J Leukocyte Biol 2000; 68: 881-889.
29. Ljunggren HG, Karre K. In search of the missing self: MHC molecules NK recognition. Immunol Today 1990; 11: 237-244.
30. Van Dijken PJ, Ghayur T, Mauch P, Down J, Burakoff SJ, Ferrara JI. Evidence that anti-LFA-1 in VIVO improves engraftment and survival after allogeneic bone marrow transplantation. Transplantation 1990; 49: 882-886.
31. Cosimi AB, Conti D, Delmonic FL et al. In vivo effects of monoclonal antibody to ICAM-1 (CD45) in non-human primates with renal allografts. J Immunol 1990; 144: 4604-4612.
32. Isobe M, Yagita H, Okumura K, Ihara A. Specific acceptance of ICAM-1 and LFA-1. Science 1992; 255: 1125-1127.
33. deFougerolles AR, Stacker SA, Schwarting R, Springer TA. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J Exp Med 1991; 174: 253-267.
34. deFougerolles AR, Springer TA. Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes. J Exp Med 1992; 175: 185-190.
35. Diamond MS, Garcia-Aguilar J, Bickford JK, Corbi AL, Springer TA. The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J Cell Biol 1993; 120: 1031-1043.
36. Postigo AA, Sanchez-Mateos P, Lazarovits AI, Sanchez-Madrid F, de Landazuri MO. Alpha 4 beta 7 integrin mediates B cell binding to fibronectin and vascular cell adhesion molecule-1. Expression and function of alpha 4 integrins on human B lymphocytes. J Immunol 1993; 151: 2471-2483.
37. Melder RJ, Koenig GC, Munn LL, Jain RK. Adhesion of activated natural killer cells to tumor necrosis factor-alpha-treated endothelium under physiological flow conditions. Nat Immunol 1996-97; 15: 154-163.